VIRICA
Live / Applied — Suspended — suspension letter mailed (as of 03 Dec 2025)
What this means for you
Not registered yet, but its 01 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98429871
- Mark type
- Stylized text
- Filed
- 01 Mar 2024
- Attorney of record
- Nicole K. McLaughlin
Goods and services
- Class 001 — Chemicals: Cell culture reagents for laboratory use, namely, for research use; cell culture reagents for scientific and research purposes; antibody reagents for scientific purposes; diagnostic reagents for medical-scientific research use; chemical preparations for the use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; biochemical preparations for scientific purposes; catalysts in the nature of small molecules for use in increasing viral yield for use in the manufacture of vaccines and viral medicines; chemical and biochemical preparations for scientific use, research use, and laboratory research use; chemical and biochemical preparations for scientific use and for scientific research use; reagents for scientific and research use, in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses, and pseudo-viral particles; chemical and biochemical preparations, agents, and reagents sold as a unit for producing viruses using transfection for scientific use and for scientific research use
- Class 040 — Treatment of materials: Biological production, namely, custom manufacture of biological preparations in the field of gene therapy and cell therapies; biological production, namely, custom manufacture of biological preparations in the field of vaccines
- Class 042 — Scientific and technological services: Scientific research and analysis for scientific research purposes in the field of gene and cell therapies; scientific research and analysis for scientific research purposes in the field of vaccines; research and development in the field of vaccines; testing services in the field of vaccines; laboratory research in the field of gene expression; research in the field of gene therapy; research and development in the medical biotechnology field; development of biotechnology; research and development in the pharmaceutical and biotechnology fields
Owner
- Virica Biotech Inc., Ottawa, Ontario, CA
Prosecution history
- 03 Dec 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 03 Dec 2025 — LETTER OF SUSPENSION E-MAILED
- 03 Dec 2025 — SUSPENSION LETTER WRITTEN
- 03 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Dec 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 10 Sept 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 10 Sept 2025 — INQUIRY TO SUSPENSION E-MAILED
- 10 Sept 2025 — SUSPENSION INQUIRY WRITTEN
- 13 Mar 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 13 Mar 2025 — LETTER OF SUSPENSION E-MAILED
- 13 Mar 2025 — SUSPENSION LETTER WRITTEN
- 12 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED